X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-12 | PI | Sylebra Capital LLC | See Remarks | S - Sale | $198.00 | -14,476 | 2,129,260 | -1% | -$2,866,279 | |||||
| DM | 2024-11-13 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $187.31 | -15,000 | 65,294 | -19% | -$2,809,589 | |||||
| M | 2024-11-08 | PI | Sylebra Capital LLC | 10% | S - Sale | $202.71 | -328,616 | 2,143,736 | -13% | -$66,614,240 | |||||
2024-11-08 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale | $200.81 | -11,549 | 6,098 | -65% | -$2,319,191 | ||||||
| DM | 2024-11-06 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $201.52 | -25,180 | 816,752 | -3% | -$5,074,261 | |||||
| M | 2024-11-05 | PI | Sylebra Capital LLC | 10% | S - Sale | $199.25 | -431,153 | 2,472,352 | -15% | -$85,906,409 | |||||
| M | 2024-11-01 | PI | Sylebra Capital LLC | 10% | S - Sale | $195.17 | -118,043 | 2,903,505 | -4% | -$23,038,514 | |||||
| M | 2024-10-29 | PI | Sylebra Capital LLC | 10% | S - Sale | $200.75 | -175,804 | 3,021,548 | -5% | -$35,291,942 | |||||
| DM | 2024-10-29 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $201.42 | -35,000 | 826,932 | -4% | -$7,049,818 | |||||
| D | 2024-10-28 | PI | Mecklai Hussein | COO | S - Sale+OE | $204.75 | -10,000 | 59,565 | -14% | -$2,047,527 | |||||
| D | 2024-10-28 | PI | Baker Cary | CFO | S - Sale+OE | $204.90 | -15,000 | 70,346 | -18% | -$3,073,471 | |||||
| D | 2024-10-14 | PI | Mecklai Hussein | COO | S - Sale+OE | $237.75 | -427 | 60,041 | -1% | -$101,520 | |||||
| D | 2024-10-14 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $237.84 | -488 | 65,294 | -1% | -$116,065 | |||||
| D | 2024-10-14 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $237.82 | -1,219 | 826,932 | 0% | -$289,901 | |||||
| D | 2024-10-14 | PI | Baker Cary | CFO | S - Sale+OE | $237.83 | -366 | 71,096 | -1% | -$87,045 | |||||
| D | 2024-09-24 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale+OE | $209.15 | -209 | 17,647 | -1% | -$43,711 | |||||
| D | 2024-09-24 | PI | Mecklai Hussein | COO | S - Sale+OE | $209.18 | -822 | 59,374 | -1% | -$171,945 | |||||
| D | 2024-09-24 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $209.20 | -577 | 64,532 | -1% | -$120,706 | |||||
| D | 2024-09-24 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $209.12 | -1,498 | 825,026 | 0% | -$313,257 | |||||
| D | 2024-09-24 | PI | Baker Cary | CFO | S - Sale+OE | $209.17 | -496 | 70,524 | -1% | -$103,747 | |||||
2024-09-13 | PI | Padval Umesh | Dir | S - Sale | $188.47 | -3,529 | 1,729 | -67% | -$665,126 | ||||||
| A | 2024-09-16 | PI | Sylebra Capital LLC | 10% | P - Purchase | $0.00 | +0 | 0 | -32768% | +$0 | |||||
| D | 2024-09-13 | PI | Sylebra Capital LLC | 10% | P - Purchase | $4.69 | +4,264,393 | 33,050,456 | +15% | +$20,000,003 | |||||
| D | 2024-08-21 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale+OE | $162.46 | -677 | 17,367 | -4% | -$109,982 | |||||
| DM | 2024-07-31 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $154.65 | -30,000 | 63,642 | -32% | -$4,639,394 | |||||
| D | 2024-07-15 | PI | Mecklai Hussein | COO | S - Sale+OE | $175.43 | -416 | 58,104 | -1% | -$72,980 | |||||
| D | 2024-07-15 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $175.38 | -475 | 63,642 | -1% | -$83,307 | |||||
| D | 2024-07-15 | PI | Baker Cary | CFO | S - Sale+OE | $175.42 | -356 | 69,760 | -1% | -$62,448 | |||||
| D | 2024-07-15 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $175.43 | -1,187 | 843,906 | 0% | -$208,234 | |||||
| D | 2024-07-08 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $162.32 | -5,000 | 841,968 | -1% | -$811,607 | |||||
| DM | 2024-07-01 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $154.76 | -10,000 | 841,968 | -1% | -$1,547,568 | |||||
| D | 2024-06-24 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale+OE | $147.52 | -212 | 16,669 | -1% | -$31,274 | |||||
| D | 2024-06-24 | PI | Mecklai Hussein | COO | S - Sale+OE | $147.58 | -833 | 57,427 | -1% | -$122,933 | |||||
| D | 2024-06-24 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $147.58 | -584 | 62,867 | -1% | -$86,189 | |||||
| D | 2024-06-24 | PI | Baker Cary | CFO | S - Sale+OE | $147.64 | -503 | 69,179 | -1% | -$74,263 | |||||
| DM | 2024-06-24 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $148.90 | -11,519 | 841,968 | -1% | -$1,715,187 | |||||
| D | 2024-06-17 | PI | Mecklai Hussein | COO | S - Sale+OE | $149.90 | -495 | 56,170 | -1% | -$74,199 | |||||
| D | 2024-06-17 | PI | Baker Cary | CFO | S - Sale+OE | $149.94 | -308 | 68,422 | 0% | -$46,182 | |||||
| D | 2024-06-17 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $149.88 | -739 | 61,986 | -1% | -$110,761 | |||||
| DM | 2024-06-17 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $149.73 | -10,616 | 839,671 | -1% | -$1,589,576 | |||||
| DM | 2024-06-10 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $147.13 | -10,000 | 838,724 | -1% | -$1,471,303 | |||||
2024-06-10 | PI | Washington Miron | Dir | S - Sale | $148.04 | -1,500 | 571 | -72% | -$222,065 | ||||||
| D | 2024-06-06 | PI | Sylebra Capital LLC | 10% | S - Sale+OE | $153.10 | -1,000,000 | 3,215,437 | -24% | -$153,100,000 | |||||
| DM | 2024-05-31 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $163.87 | -15,000 | 838,724 | -2% | -$2,457,979 | |||||
| D | 2024-05-21 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale+OE | $166.99 | -708 | 16,468 | -4% | -$118,227 | |||||
| D | 2024-05-02 | PI | Baker Cary | CFO | S - Sale+OE | $159.08 | -10,000 | 67,948 | -13% | -$1,590,800 | |||||
| D | 2024-05-01 | PI | Mecklai Hussein | COO | S - Sale+OE | $154.38 | -5,000 | 55,414 | -8% | -$771,882 | |||||
2024-04-26 | PI | Padval Umesh | Dir | S - Sale | $151.39 | -3,475 | 3,529 | -50% | -$526,074 | ||||||
2024-04-26 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale | $147.94 | -10,000 | 15,801 | -39% | -$1,479,359 | ||||||
| D | 2024-04-26 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $145.77 | -8,000 | 60,850 | -12% | -$1,166,128 | |||||
| D | 2024-04-26 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $147.02 | -26,661 | 838,724 | -3% | -$3,919,790 | |||||
| D | 2024-04-15 | PI | Mecklai Hussein | COO | S - Sale+OE | $118.75 | -435 | 55,414 | -1% | -$51,656 | |||||
| D | 2024-04-15 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $118.70 | -498 | 60,850 | -1% | -$59,111 | |||||
| D | 2024-04-15 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $118.67 | -1,244 | 858,724 | 0% | -$147,626 | |||||
| D | 2024-04-15 | PI | Baker Cary | CFO | S - Sale+OE | $118.70 | -374 | 67,948 | -1% | -$44,393 | |||||
| D | 2024-03-25 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale+OE | $126.84 | -841 | 25,801 | -3% | -$106,668 | |||||
| D | 2024-03-25 | PI | Mecklai Hussein | COO | S - Sale+OE | $126.83 | -1,456 | 54,755 | -3% | -$184,667 | |||||
| D | 2024-03-25 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $126.95 | -1,208 | 60,098 | -2% | -$153,361 | |||||
| D | 2024-03-25 | PI | Baker Cary | CFO | S - Sale+OE | $127.61 | -1,062 | 67,384 | -2% | -$135,524 | |||||
| D | 2024-03-25 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $127.19 | -2,953 | 856,843 | 0% | -$375,595 | |||||
| D | 2024-03-19 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $119.48 | -3,000 | 58,253 | -5% | -$358,430 | |||||
| D | 2024-03-18 | PI | Mecklai Hussein | COO | S - Sale+OE | $124.38 | -489 | 52,533 | -1% | -$60,822 | |||||
| D | 2024-03-18 | PI | Baker Cary | CFO | S - Sale+OE | $123.55 | -306 | 65,748 | 0% | -$37,806 | |||||
| D | 2024-03-18 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $123.56 | -612 | 852,307 | 0% | -$75,620 | |||||
| DM | 2024-03-14 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $123.21 | -9,732 | 58,253 | -14% | -$1,199,073 | |||||
| D | 2024-02-27 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $105.00 | -5,000 | 851,357 | -1% | -$525,000 | |||||
| DM | 2024-02-23 | PI | Baker Cary | CFO | S - Sale+OE | $101.75 | -6,284 | 65,273 | -9% | -$639,398 | |||||
2024-02-23 | PI | Mecklai Hussein | COO | S - Sale | $101.15 | -7,217 | 51,772 | -12% | -$730,026 | ||||||
2024-02-23 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale | $101.11 | -4,858 | 57,110 | -8% | -$491,210 | ||||||
| DM | 2024-02-23 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $102.07 | -21,060 | 851,357 | -2% | -$2,149,633 | |||||
| D | 2024-02-21 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale+OE | $98.88 | -2,556 | 24,990 | -9% | -$252,745 | |||||
| D | 2024-02-15 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale+OE | $106.23 | -10,000 | 21,750 | -31% | -$1,062,289 | |||||
| DM | 2024-02-15 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $105.16 | -10,000 | 825,805 | -1% | -$1,051,618 | |||||
| D | 2024-02-14 | PI | Baker Cary | CFO | S - Sale+OE | $102.14 | -20,000 | 55,432 | -27% | -$2,042,755 | |||||
| D | 2024-02-12 | PI | Mecklai Hussein | COO | S - Sale+OE | $104.80 | -30,000 | 40,489 | -43% | -$3,143,865 | |||||
| D | 2024-01-16 | PI | Mecklai Hussein | COO | S - Sale+OE | $81.13 | -325 | 40,489 | -1% | -$26,368 | |||||
| D | 2024-01-16 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $81.16 | -855 | 825,805 | 0% | -$69,394 | |||||
| D | 2024-01-16 | PI | Baker Cary | CFO | S - Sale+OE | $81.19 | -278 | 55,432 | 0% | -$22,572 | |||||
| D | 2024-01-16 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $81.17 | -371 | 46,118 | -1% | -$30,115 | |||||
| D | 2023-12-26 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $89.76 | -1,001 | 823,535 | 0% | -$89,846 | |||||
| D | 2023-12-26 | PI | Mecklai Hussein | COO | S - Sale+OE | $89.73 | -603 | 39,720 | -1% | -$54,109 | |||||
| D | 2023-12-26 | PI | Baker Cary | CFO | S - Sale+OE | $89.64 | -302 | 54,773 | -1% | -$27,071 | |||||
| D | 2023-12-26 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $89.75 | -362 | 45,239 | -1% | -$32,488 | |||||
| D | 2023-12-18 | PI | Mecklai Hussein | COO | S - Sale+OE | $88.85 | -495 | 38,761 | -1% | -$43,979 | |||||
| D | 2023-12-18 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $88.84 | -616 | 821,942 | 0% | -$54,726 | |||||
| D | 2023-12-18 | PI | Baker Cary | CFO | S - Sale+OE | $88.84 | -308 | 54,294 | -1% | -$27,364 | |||||
| D | 2023-12-18 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $88.83 | -739 | 44,664 | -2% | -$65,644 | |||||
| D | 2023-11-27 | PI | Baker Cary | CFO | S - Sale+OE | $82.94 | -1,468 | 53,821 | -3% | -$121,749 | |||||
2023-11-20 | PI | Sylebra Capital Ltd | 10% | P - Purchase | $82.91 | +37,513 | 4,197,352 | +1% | +$3,110,203 | ||||||
2023-11-17 | PI | Sylebra Capital Ltd | 10% | P - Purchase | $81.01 | +41,252 | 4,159,839 | +1% | +$3,341,825 | ||||||
2023-11-15 | PI | Sylebra Capital Ltd | 10% | P - Purchase | $79.97 | +52,518 | 4,083,077 | +1% | +$4,199,864 | ||||||
2023-11-16 | PI | Sylebra Capital Ltd | 10% | P - Purchase | $79.61 | +35,510 | 4,118,587 | +1% | +$2,826,951 | ||||||
2023-11-14 | PI | Sylebra Capital Ltd | 10% | P - Purchase | $79.44 | +48,311 | 4,030,559 | +1% | +$3,837,826 | ||||||
2023-11-13 | PI | Sylebra Capital Ltd | 10% | P - Purchase | $73.16 | +33,682 | 3,982,248 | +1% | +$2,464,175 | ||||||
2023-10-26 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale | $62.08 | -1,000 | 40,198 | -2% | -$62,080 | ||||||
| D | 2023-10-13 | PI | Mecklai Hussein | COO | S - Sale+OE | $52.40 | -436 | 38,006 | -1% | -$22,846 | |||||
| D | 2023-10-13 | PI | Dossett Jeffrey | Chief Revenue Officer | S - Sale+OE | $52.37 | -498 | 41,198 | -1% | -$26,080 | |||||
| D | 2023-10-13 | PI | Diorio Chris Ph.D. | CEO | S - Sale+OE | $52.39 | -1,245 | 876,495 | 0% | -$65,227 | |||||
| D | 2023-10-13 | PI | Baker Cary | CFO | S - Sale+OE | $52.26 | -375 | 51,539 | -1% | -$19,596 | |||||
| D | 2023-10-02 | PI | Phelan Cathal G | Chief Innovation Officer | S - Sale+OE | $53.29 | -1,082 | 21,750 | -5% | -$57,657 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |